| Identification | Back Directory | [Name]
methyl 12-methoxy-13-(17-methoxy-17-oxovobasan-3alpha-yl)ibogamine-18-carboxylate | [CAS]
3371-85-5 | [Synonyms]
MMH 18
NSC 82591
voacamine
Voacanginine
methyl 12-methoxy-13-(17-methoxy-17-oxovobasan-3alpha-yl)ibogamine-18-carboxylate
12-Methoxy-13-[(3α)-17-methoxy-17-oxovobasan-3-yl]ibogamine-18-carboxylic acid methyl ester
methyl 12-methoxy-13-(17-methoxy-17-oxovobasan-3alpha-yl)ibogamine-18-carboxylate USP/EP/BP
Ibogamine-18-carboxylic acid, 12-methoxy-13-[(3α)-17-methoxy-17-oxovobasan-3-yl]-, methyl ester | [EINECS(EC#)]
222-151-3 | [Molecular Formula]
C43H52N4O5 | [MDL Number]
MFCD30723103 | [MOL File]
3371-85-5.mol | [Molecular Weight]
704.907 |
| Chemical Properties | Back Directory | [Melting point ]
223℃ (dec.) (methanol ) | [alpha ]
D20 -52° (chloroform) | [density ]
1.30±0.1 g/cm3 (20 ºC 760 Torr) | [storage temp. ]
Store at -20°C | [solubility ]
DMF: 30 mg/ml; DMSO: 20 mg/ml; Ethanol: 5 mg/ml | [form ]
A crystalline solid |
| Hazard Information | Back Directory | [Uses]
Voacamine has shown activity against Leishmania ultrastructure through poisoning the bi-subunit topoisomerase IB. | [Definition]
ChEBI: Voacamine is a citraconoyl group. |
|
|